Hunziker W, Walters M R, Bishop J E, Norman A W
J Clin Invest. 1982 Apr;69(4):826-33. doi: 10.1172/jci110522.
The dynamic equilibrium between in vivo occupied and unoccupied 1,25-dihydroxyvitamin D(3)[1,25(OH)(2)D(3)] receptors of the chick intestinal mucosa was investigated by the exchange assay previously reported [(1980). J. Biol. Chem.255: 9534-9537]. These parameters and their correlation to biological response, i.e., the levels of intestinal vitamin D-dependent calcium binding protein (CaBP), were assessed under different physiological conditions. After a single 1,25(OH)(2)D(3) injection (3.25 nmol), occupied receptor levels increased sharply to a maximum between 1 and 2 h, followed by a rapid decline. A single dose of 1alpha-hydroxy-vitamin D(3) [1alpha(OH)D(3)], an analog that requires 25-hydroxylation for biological activity, resulted in a protracted, albeit lower, response with maximal receptor occupancy at 6 h and half maximal levels 24 h after injection. The intestinal receptor occupancy patterns mirrored the serum 1,25(OH)(2)D(3) levels after either 1,25(OH)(2)D(3) or 1alpha(OH)D(3) treatment. Additionally, time-course (half-life) of blood disappearance of 1,25(OH)(2)D(3) and occupied receptor levels were similar (1.9 and 2.3 h, respectively), suggesting that the amount of occupied 1,25(OH)(2)D(3) receptor is determined by a simple equilibrium between serum 1,25(OH)(2)D(3) and unoccupied receptors. A dose-response study after intramuscular 1,25(OH)(2)D(3) injection yielded a hyperbolic curve with an apparent plateau at 70% receptor occupancy, corresponding to 5 nmol 1,25(OH)(2)D(3) injected. Half-maximal occupancy was reached after a dose of 1 nmol 1,25(OH)(2)D(3), corresponding to 1.5 ng 1,25(OH)(2)D(3)/ml serum. From this value the apparent K(d) in vivo is 3.7 nM, which is similar to that determined in vitro. A 10-fold increase in the 1alpha(OH)D(3) dose resulted in less than a doubling of the levels of serum 1,25(OH)(2)D(3), occupied 1,25(OH)(2)D(3) receptors, or CaBP. Under all experimental conditions, there was a positive correlation between occupied receptor and CaBP levels; however, the slope of the lines depended on the times chosen for the assays due in part to the lag period for CaBP induction and its accumulation within the cell. Conversely, the correlation between serum 1,25-(OH)(2)D(3) levels and occupied receptor levels yielded a single regression line independent of the observation time. Short and long-term treatment with different vitamin D metabolites, estrogen, progesterone, or cortisol did not affect the levels of total intestinal 1,25(OH)(2)D(3) receptor. Under normal physiological conditions, only 10-15% of the total 1,25(OH)(2)D(3) receptor population was occupied by ligand. These studies provide a basis for further investigations of physiological and biochemical parameters of the vitamin D endocrine system and their clinical applications.
通过先前报道的交换试验[(1980)。《生物化学杂志》255:9534 - 9537]研究了雏鸡肠黏膜中体内已占据和未占据的1,25 - 二羟基维生素D(3)[1,25(OH)(2)D(3)]受体之间的动态平衡。在不同生理条件下评估了这些参数及其与生物学反应的相关性,即肠道维生素D依赖性钙结合蛋白(CaBP)的水平。单次注射1,25(OH)(2)D(3)(3.25 nmol)后,已占据的受体水平在1至2小时内急剧上升至最大值,随后迅速下降。单剂量的1α - 羟基维生素D(3)[1α(OH)D(3)],一种需要25 - 羟化才能具有生物学活性的类似物,导致了一种持续时间较长但较低的反应,在注射后6小时达到最大受体占有率,24小时达到半最大水平。1,25(OH)(2)D(3)或1α(OH)D(3)处理后,肠道受体占有率模式反映了血清1,25(OH)(2)D(3)水平。此外,1,25(OH)(2)D(3)血液消失的时间进程(半衰期)和已占据的受体水平相似(分别为1.9小时和2.3小时),这表明已占据的1,25(OH)(2)D(3)受体数量由血清1,25(OH)(2)D(3)和未占据受体之间的简单平衡决定。肌肉注射1,25(OH)(2)D(3)后的剂量反应研究产生了一条双曲线,在受体占有率为70%时出现明显平台期,对应于注射5 nmol 1,25(OH)(2)D(3)。注射1 nmol 1,25(OH)(2)D(3)后达到半最大占有率,相当于血清中1.5 ng 1,25(OH)(2)D(3)/ml。由此值计算出体内的表观解离常数(K(d))为3. nM,这与体外测定的值相似。1α(OH)D(3)剂量增加10倍导致血清1,25(OH)(2)D(3)、已占据的1,25(OH)(2)D(3)受体或CaBP水平增加不到两倍。在所有实验条件下,已占据的受体与CaBP水平之间呈正相关;然而,由于CaBP诱导的滞后时间及其在细胞内的积累,曲线斜率取决于测定所选择的时间。相反,血清1,25 - (OH)(2)D(3)水平与已占据的受体水平之间的相关性产生了一条与观察时间无关的单一回归线。用不同的维生素D代谢物、雌激素、孕酮或皮质醇进行短期和长期处理均不影响肠道1,25(OH)(2)D(3)总受体水平。在正常生理条件下,只有10 - 15%的1,25(OH)(2)D(3)受体总数被配体占据。这些研究为进一步研究维生素D内分泌系统的生理和生化参数及其临床应用提供了基础。